Our new clinical investigator FMV study focuses on promoting transparency by building accurate calculation procedures, establishing investigator payment schedules to keep trials on track and organizing successful investigator meetings while staying within a budget. The report also includes key performance indicators, such as pass-through/direct cost benchmarks, average investigator compensation across nine therapeutic areas, annual compensation limits for principal investigators, and cost-per-attendee metrics for investigator meetings.
Harness companion diagnostic metrics to set strategy, improve partner selection and build a program of targeted therapy development. Ratings and benchmarks explore resource levels and therapeutic area details.
Design and execute Phase IV (4) clinical trials with trial timelines, budget benchmarks, and breakdowns of trial management and strategy.
Explore the next frontier of emerging markets to build a clinical foundation that generates decades of benefits for developers and patients.
Boost trials with Latin America’s untapped clinical promise, including patient availability, established infrastructure, and convenient communication.
Make sense of Europe’s emerging markets to accelerate clinical development and save money while addressing region-specific challenges.
Navigate the maze of emerging Asian markets to improve patient access and retention while sidestepping clinical teams' common mistakes.
Confidently tap BRIC's potential to deliver patients and lower costs while avoiding the pitfalls common to these new markets.
Chart a comprehensive recruiting and retention strategy with specific tools, processes and resource benchmarks.
Benchmark unit hour costs, project budgets and trial timelines to make the most of your clinical outsourcing strategy.
Build a transparent compensation system based on fair-market value to attract investigators while avoiding compliance pitfalls.